<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><meta http-equiv="Content-Language" content="en" /><title>Verbatim report of proceedings - Medicine shortages and strategic healthcare autonomy in the EU (debate) - Tuesday, 3 October 2023</title><meta name="title" content="Verbatim report of proceedings - Medicine shortages and strategic healthcare autonomy in the EU (debate) - Tuesday, 3 October 2023" /><meta name="language" content="en" /><meta name="robots" content="index, follow, noodp, noydir, notranslate" /><meta name="copyright" content="© European Union, 2023 - Source: European Parliament" /><meta name="available" content="03-10-2023" /><meta name="sipade-leg" content="9" /><meta name="sipade-type" content="CRE" /><meta property="og:title" content="Verbatim report of proceedings - Medicine shortages and strategic healthcare autonomy in the EU (debate) - Tuesday, 3 October 2023" /><meta property="og:image" content="https://www.europarl.europa.eu/website/common/img/icon/sharelogo_facebook.jpg" /><link rel="canonical" href="https://www.europarl.europa.eu/doceo/document/CRE-9-2023-10-03-ITM-012_EN.html" /><link href="/doceo/data/css/style_common.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_common_print.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_sipade.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_activities.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/common_sides.css" type="text/css" rel="stylesheet" /><link href="/doceo/data/css/style_sipade_oj_sched.css" type="text/css" rel="stylesheet" />
<script src="/doceo/data/js/overlib.js" type="text/javascript"> </script>
<script src="/doceo/data/js/swap_images.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade.js" type="text/javascript"> </script>
<script src="/doceo/data/js/jquery-1.4.4.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade-OJ-SYN.js" type="text/javascript"> </script><!--ATI analytics script--><script type="text/javascript" data-tracker-name="ATInternet" defer data-value="/website/webanalytics/ati-doceo.js" src="//www.europarl.europa.eu/website/privacy-policy/privacy-policy.js" ></script></head><body bgcolor="#FFFFFF"><div id="overDiv" style="position:absolute; visibility:hidden; z-index:1000;"> </div><a name="top"></a><table cellpadding="0" cellspacing="0" border="0" width="100%"><tr><td><div id="header_sides" class="new">
<a href="/portal/en"><img alt="Go back to the Europarl portal" title="Go back to the Europarl portal" src="/doceo/data/img/EP_logo_neg_EN.png" /></a><h3 class="ep_hidden">Choisissez la langue de votre document :</h3><ul class="language_select">
            <li><a title="bg - български" class="bg on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_BG.html">bg - български</a></li>
            <li><a title="es - español" class="es on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_ES.html">es - español</a></li>
            <li><a title="cs - čeština" class="cs on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_CS.html">cs - čeština</a></li>
            <li><a title="da - dansk" class="da on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_DA.html">da - dansk</a></li>
            <li><a title="de - Deutsch" class="de on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_DE.html">de - Deutsch</a></li>
            <li><a title="et - eesti keel" class="et on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_ET.html">et - eesti keel</a></li>
            <li><a title="el - ελληνικά" class="el on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_EL.html">el - ελληνικά</a></li>
            <li class="en selected" title="en - English">en - English<span> (Selected)</span></li>
            <li><a title="fr - français" class="fr on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_FR.html">fr - français</a></li>
            <li><a title="ga - Gaeilge" class="ga on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_GA.html">ga - Gaeilge</a></li>
            <li><a title="hr - hrvatski" class="hr on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_HR.html">hr - hrvatski</a></li>
            <li><a title="it - italiano" class="it on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_IT.html">it - italiano</a></li>
            <li><a title="lv - latviešu valoda" class="lv on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_LV.html">lv - latviešu valoda</a></li>
            <li><a title="lt - lietuvių kalba" class="lt on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_LT.html">lt - lietuvių kalba</a></li>
            <li><a title="hu - magyar" class="hu on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_HU.html">hu - magyar</a></li>
            <li><a title="mt - Malti" class="mt on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_MT.html">mt - Malti</a></li>
            <li><a title="nl - Nederlands" class="nl on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_NL.html">nl - Nederlands</a></li>
            <li><a title="pl - polski" class="pl on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_PL.html">pl - polski</a></li>
            <li><a title="pt - português" class="pt on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_PT.html">pt - português</a></li>
            <li><a title="ro - română" class="ro on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_RO.html">ro - română</a></li>
            <li><a title="sk - slovenčina" class="sk on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_SK.html">sk - slovenčina</a></li>
            <li><a title="sl - slovenščina" class="sl on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_SL.html">sl - slovenščina</a></li>
            <li><a title="fi - suomi" class="fi on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_FI.html">fi - suomi</a></li>
            <li><a title="sv - svenska" class="sv on" href="/doceo/document/CRE-9-2023-10-03-ITM-012_SV.html">sv - svenska</a></li>
        </ul></div></td></tr><tr><td style="padding:10px;"><table width="100%" border="0" cellspacing="0" cellpadding="0"><tr><td><table border="0" align="left" cellpadding="0" cellspacing="0"><tr><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-9-2023-10-03-TOC_EN.html"><img src="/doceo/data/img/navi_index.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-9-2023-10-03-TOC_EN.html" title="Index">Index</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-9-2023-10-03-ITM-011_EN.html"><img src="/doceo/data/img/navi_previous.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-9-2023-10-03-ITM-011_EN.html" title="Previous">Previous</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td valign="middle"> <a href="/doceo/document/CRE-9-2023-10-03-ITM-013_EN.html" title="Next">Next</a> </td><td><a href="/doceo/document/CRE-9-2023-10-03-ITM-013_EN.html"><img src="/doceo/data/img/navi_next.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-9-2023-10-03_EN.html"><img src="/doceo/data/img/navi_moredetails.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-9-2023-10-03_EN.html" title="Full text">Full text</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td></tr><tr><td><img src="/doceo/data/img/spacer.gif" width="10" height="15" alt="" /></td></tr></table></td></tr></table><table width="100%" border="0" cellpadding="5" cellspacing="0" class="doc_box_header">
<tr>
<td align="left" valign="top" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="title_TA">Verbatim report of proceedings</td><td valign="top" align="right" style="background-image:url(/doceo/data/img/gradient_blue.gif)">
<table border="0" cellspacing="0" cellpadding="0"><tr>
<td><a href="/doceo/document/CRE-9-2023-10-03-ITM-012_EN.xml"><img src="/doceo/data/img/formats/icn_xml.gif" border="0" align="bottom" alt="XML" title="XML" /></a><span class="doc_size"> 86k</span></td></tr>
</table></td>
</tr>
<tr>
<td class="doc_title" align="left" valign="top" bgcolor="#F5F5F5">Tuesday, 3 October 2023 - Strasbourg</td>
<td class="doc_title" align="right" valign="top" bgcolor="#F5F5F5">Provisional edition</td></tr></table><br />
<table width="100%" border="0" cellpadding="0" cellspacing="0" class="doc_box_header" style="padding-bottom:5px"><tr valign="top"><td>
<table width="100%" border="0" cellpadding="5" cellspacing="0"><tr valign="top" style="padding-bottom:0px;padding-left:5px;padding-right:5px;padding-top:5px"><td align="left" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="doc_title"><img src="/doceo/data/img/arrow_title_doc.gif" width="8" height="14" border="0" align="absmiddle" alt="" /> 12. Medicine shortages and strategic healthcare autonomy in the EU (debate)</td><td style="background-image:url(/doceo/data/img/gradient_blue.gif)" width="10"><table cellSpacing="0" cellPadding="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=chapter&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:11:58&amp;playerEndTime=20231003-15:19:30" target="_blank"><img width="29" height="20" src="/doceo/data/img/vod_all_speakers_left.gif" border="0" /></a></td><td class="switch_button_pv_cre"><a title="Video of the speeches" href="/plenary/en/vod.html?mode=chapter&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:11:58&amp;playerEndTime=20231003-15:19:30" target="_blank">Video of the speeches</a></td><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=chapter&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:11:58&amp;playerEndTime=20231003-15:19:30" target="_blank"><img width="5" height="20" src="/doceo/data/img/switch_pv_cre_right.gif" border="0" /></a></td></tr></table></td><td style="background-image:url(/doceo/data/img/gradient_blue.gif)" width="10"><table align="right" cellpadding="0" cellspacing="0"><tr><td><a href="/doceo/document/PV-9-2023-10-03-ITM-012_EN.html" title="Minutes"><img src="/doceo/data/img/switch_pv_cre_left.gif" width="22" height="20" border="0" alt="" /></a></td><td class="switch_button_pv_cre"><a href="/doceo/document/PV-9-2023-10-03-ITM-012_EN.html" title="Minutes">PV</a></td><td><a href="/doceo/document/PV-9-2023-10-03-ITM-012_EN.html" title="Minutes"><img src="/doceo/data/img/switch_pv_cre_right.gif" width="5" height="20" border="0" alt="" /></a></td></tr></table></td></tr></table>
<a name="2-232-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28586.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:11:58&amp;playerEndTime=20231003-14:12:32" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Πρόεδρος. – </span></span>  Το επόμενο σημείο στην ημερήσια διάταξη είναι η συζήτηση επί της δήλωσης της Επιτροπής σχετικά με τις ελλείψεις φαρμάκων και στρατηγική αυτονομία στον τομέα της υγειονομική περίθαλψης στην ΕΕ ((<a href="https://oeil.secure.europarl.europa.eu/oeil/popups/ficheprocedure.do?lang=en&amp;reference=2023/2877(RSP)">2023/2877(RSP)</a>).</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-233-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/doceo/data/img/photo_generic.gif" align="right" width="50" height="63" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:12:32&amp;playerEndTime=20231003-14:17:41" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Stella Kyriakides,</span></span>   <span class="italic">Member of the Commission</span><span class="bold">.</span> – Mr President, honourable Members, first of all, I want to thank you for inviting me today and for the opportunity to discuss medicine shortages and the need for strategic autonomy in health.</p>
<p class="contents">The continued availability of safe and effective and affordable medicines for all European patients has been a top priority for many of us since the very beginning of this mandate. This is the foundation of a strong European Union in health that we have been building. Last winter was a strong reminder that we need to act to make Europe’s medicine supply chains more resilient.</p>
<p class="contents">When EU action is necessary to manage critical shortages, the Commission steps in to support Member States, working closely with the European Medicines Agency. We use all tools available under the Agency’s extended mandate regulation to manage and mitigate those shortages and engage with the industry so that medicines can reach all those that need them across the EU.</p>
<p class="contents">But we are also taking steps to prevent shortages. Our pharmaceutical reform aims to enhance security of supply and addresses shortages of medicines beyond crisis situations. Key elements include a new European alert system so that we have an earlier notification of shortages and withdrawals by companies, harmonised reporting criteria, shortage prevention plans and coordinated management of shortages by EMA.</p>
<p class="contents">These measures will equip us better to anticipate and mitigate shortages, avoid national export restrictions, and ultimately achieve what we are all trying to do, and that is ensure that medicines are available for all patients. But they are more structural in nature and more for in the long term.</p>
<p class="contents">This is why in the coming weeks, we will be putting forward a communication, including short- and mid-term actions, to enhance the security of supply and make the supply chains of medicines more resilient. This responds to calls from the public, from this House and from the Member States for more immediate actions on availability of medicines ahead of the winter seasons because we saw what we had to face last year.</p>
<p class="contents">This communication will complement our regulatory efforts by encouraging Member States to anticipate the many relevant steps under the pharmaceutical reform. We will also adopt a Union list of critical medicines for the first time. We will institutionalise the voluntary cooperation and establish the European Solidarity Mechanism to support Member States to tackle the shortages of medicines this winter in a coordinated but also in a timely way.</p>
<p class="contents">Finally, we are going to be building on the strategic relations with all our international partners to achieve supply chain diversity and global solidarity. In line with the Council recommendation, we are also stepping up the fight against AMR. One concrete example is the creation and implementation of a Union multi-country pool incentive scheme for antibiotics.</p>
<p class="contents">Dear Members, I have stood here many times and we have discussed the issue of availability of medicines for all EU citizens, no matter where they live in the EU, and shared that this needs to be what we are working towards. This is our joint political responsibility. No matter where a citizen lives across the EU, whether it is in a big or small Member State, they need to have access to medicines.</p>
<p class="contents">I assure you that this Commission will continue to take very concrete and collaborative steps to achieve these goals. But the success ultimately depends on all our joint efforts with the stakeholders, with the public authorities, at European level, at national level. And I will count on your strong support to move forward with the pharmaceutical reform in a rapid way and with other initiatives which aim to deliver medicines to all citizens.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-234-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197417.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:17:49&amp;playerEndTime=20231003-14:21:22" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Tomislav Sokol, </span></span>  <span class="italic">u ime kluba PPE</span><span class="bold">.</span> – Poštovani predsjedavajući, povjerenice, kolegice i kolege, nestašice lijekova predstavljaju sve veću prijetnju javnom zdravlju u EU-u, naročito u slabije razvijenim i manjim državama članicama. </p>
<p class="contents">Posljedice takvih nestašica uključuju smanjenu kvalitetu liječenja i stvaraju nejednakosti među pacijentima, ovisno o zemlji u kojoj žive. U razdoblju od 2017. do 2019. obavijesti o nestašici lijekova u Uniji su se povećale za čak 60 %, a pritom lijekovi za liječenje raka, infekcija i poremećaja živčanog sustava čine više od polovine lijekova kojih nema dovoljno, što je apsolutno nedopustivo. </p>
<p class="contents">Nadam se i vjerujem da će revizija EU zakonodavstva o lijekovima pomoći u rješavanju problema istinskih nestašica u svakom trenutku. Novim zakonodavstvom moramo poboljšati praćenje i ublažavanje nestašica lijekova, osobito onih kritičnih. </p>
<p class="contents">Odredbe prema kojima će farmaceutska poduzeća morati brže izvješćivati o nestašicama lijekova te biti obvezne uspostaviti planove za sprečavanje nestašica generalno predstavljaju korak u dobrom smjeru, mada svakako ima prostora za poboljšanje, posebno vezano uz rokove. Pri tome je ključno da svi građani Unije imaju jednak pristup lijekovima, a ne da imamo građane prvog i drugog reda kao što je sada slučaj, što je u svakom slučaju neprihvatljivo. </p>
<p class="contents">S druge strane, sve što se događalo u posljednje tri godine pokazalo je da EU mora ozbiljno poraditi na vlastitoj strateškoj autonomiji u području zdravstva ukoliko ne želimo da netko drugi u budućnosti odlučuje o našim životima i našem zdravlju. </p>
<p class="contents">Prije nekoliko desetljeća Europa imala vrlo jak položaj u istraživanju i inovacijama u zdravstvu, ali je u velikoj mjeri tu prednost izgubila. Danas, unatoč nekim iznimkama, većina inovacija i inovativnih tvrtki nalazi se negdje drugdje. EU sve više zaostaje u razvoju i proizvodnji inovativnih lijekova u usporedbi sa SAD-om. </p>
<p class="contents">Ako pored toga uzmemo u obzir eksplozivan rast Kine, vidimo da je situacija izuzetno zabrinjavajuća i dugoročno strašno opasna. Moramo stvoriti okruženje koje privlači, a ne stvara prepreke proizvođačima novih inovativnih lijekova, posebno zahtjevnim područjima poput rijetkih dječjih bolesti gdje smo najslabiji. </p>
<p class="contents">To uključuje poticaje, zaštitu intelektualnog vlasništva, ali i mjere industrijske politike koje idu puno šire od samog farmaceutskog paketa o kojem u posljednje vrijeme toliko raspravljamo. </p>
<p class="contents">Birokratizacija i regulatorni tereti koji su, nažalost, sve veći ne smiju postati toliki da naruše temelje naše zdravstvene zaštite, smanje dostupnost lijekova, na taj način ugroze ljudske živote. </p>
<p class="contents">Sve u svemu, mislim da je farmaceutska reforma koju je predložila Europska komisija korak u dobrom smjeru. Mislim da ona adresira one ključne probleme s kojima se moramo suočiti, ali, naravno, postoji prostora za napredak. </p>
<p class="contents">Međutim, ono što je posebno važno je da to nije jedino rješenje, da postoje druga područja europskog zakonodavstva o kojima se mora razmisliti, poput direktiva o transparentnosti, poput revizije propisa o prekograničnoj zdravstvenoj zaštiti, kako bismo stvorili ono što želimo, a to je jedinstveno tržište, doista jedinstveno tržište lijekova u Europskoj uniji i kako bi se omogućilo da doista svi građani Europske unije imaju dostupnost lijekova na isti način u istom trenutku. </p>
<p class="contents">Imamo još puno posla. Europska unija doista tu može pružiti dodanu vrijednost u odnosu na situaciju kakvu imamo sada kada je puno toga još uvijek fragmentirano, ali moramo svi skupa djelovati zajedno kako bismo doista omogućili da naši pacijenti dobiju one lijekove koje trebaju, da dobiju najkvalitetnije lijekove u najkraćem mogućem roku i da svi imaju pravo na jednaku zdravstvenu zaštitu. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-235-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197718.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:21:29&amp;playerEndTime=20231003-14:24:05" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nicolás González Casares, </span></span>  <span class="italic">en nombre del Grupo S&amp;D</span><span class="bold">.</span> – Señor presidente, señora comisaria, gracias por responder a nuestra petición de debate y venir hoy al Parlamento. </p>
<p class="contents">Lo cierto es que en la Unión Europea faltan medicamentos. Se informa de desabastecimientos en todos los Estados miembros y la situación ha ido a más en los últimos años: ha habido un empeoramiento incluso desde 2022. Tenemos una gran dependencia de países externos, como China o la India, que producen hasta el 80 % de los principios activos y el 40 % de los medicamentos que consumimos en Europa. Y que no se nos olvide la situación crítica durante la pandemia. </p>
<p class="contents">Por otro lado, en la Unión Europea también estamos perdiendo la iniciativa en investigación e innovación y nos estamos quedando a la zaga de los Estados Unidos y de China. Nos faltan medicamentos esenciales y eso se traduce en miles y miles de pacientes que no pueden acceder a sus medicamentos, en niños que no pueden recibir exactamente los medicamentos y las fórmulas pediátricas que necesitan, en problemas para los pacientes con enfermedades raras, o en antibióticos que no son exactamente los prescritos por el médico y que pueden aumentar las resistencias a los antimicrobianos. </p>
<p class="contents">La Comisión ya señaló en su Estrategia Industrial de 2021 que los principios activos farmacéuticos eran uno de los seis elementos clave en cuanto a las dependencias de la Unión. Y, aunque hemos propuesto legislaciones o medidas de apoyo, por ejemplo, en relación con los semiconductores o las baterías, no lo hemos hecho en el ámbito farmacéutico. Necesitamos un esfuerzo inversor en este campo y estrategias dedicadas a aumentar nuestra producción y a reducir nuestra dependencia farmacéutica de otros países. Se notifican desabastecimientos y la nueva legislación farmacéutica contempla un seguimiento al respecto. Eso está muy bien: ya lo defendimos durante la reforma de la Agencia Europea de Medicamentos, en la que fui ponente. </p>
<p class="contents">Pero necesitamos algo más, y por eso, señora comisaria, le hemos hecho esta pregunta conjunta entre varios grupos: ¿cuáles son las iniciativas de la Comisión en este campo? ¿Cómo vamos a solventar de verdad, mediante nuestra producción industrial, los problemas de desabastecimientos? ¿Cómo vamos a aumentar la transparencia? ¿Cómo hemos visto estos días que ese elemento que es la Autoridad de Preparación y Respuesta ante Emergencias Sanitarias —que no podemos controlar desde este Parlamento— está renegociando por su cuenta y favoreciendo que solo haya una solución vacunal para los próximos años en lo que tiene que ver con la COVID-19? Queremos respuestas, señora comisaria. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-236-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197784.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:24:10&amp;playerEndTime=20231003-14:25:24" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Susana Solís Pérez, </span></span>  <span class="italic">en nombre del Grupo Renew</span><span class="bold">.</span> – Señor presidente, señora comisaria, traemos un debate muy importante a este Pleno porque la escasez de medicamentos, como pueden ser antibióticos o medicamentos para niños, es un problema recurrente y crónico. Y la situación empeora cada vez más. </p>
<p class="contents">Pero, además, la Unión Europea depende ya de forma peligrosa de muy pocos fabricantes y regiones, especialmente de China y de la India, y sufrimos una pérdida constante de competitividad en un sector en el que hemos sido líderes. Vamos encaminados hacia una situación vulnerable. Y no podemos limitarnos solo a mitigar las carencias actuales: hay que prevenir. La Comisión ya ha reconocido que esta área es clave para nuestra autonomía estratégica. Lo que pedimos es actuar; lo que pedimos es una política clara para apoyar la innovación y la producción de medicamentos esenciales <span class="italic">made in Europe</span>. </p>
<p class="contents">Esto no solo es clave para nuestra resiliencia ante futuras crisis, sino que también acelerará el acceso a tratamientos para nuestros pacientes, garantizará la sostenibilidad de nuestros sistemas de salud, impulsará un sector biotecnológico en el que Europa era líder, y generará empleos y prosperidad para todos. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-237-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/193292.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:25:32&amp;playerEndTime=20231003-14:27:45" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Tilly Metz, </span></span>  <span class="italic">au nom du groupe Verts/ALE</span><span class="bold">.</span> – Madame la Présidente, Madame la Commissaire, comme mes collègues, je pense qu’il est crucial d’aborder la question de l’action européenne pour faire face aux pénuries de médicaments. Je me réjouis que la Commission prépare une communication sur le sujet et j’attends des actions fortes, notamment sur trois points.</p>
<p class="contents">Premièrement, demander la transparence des chaînes de production auprès des entreprises qui nous approvisionnent. Nous avons besoin de mieux comprendre où se situent les problèmes sur les chaînes de production. Bien sûr, la transparence signifie aussi être informés suffisamment tôt des pénuries et de leurs raisons. Si une entreprise interrompt la production d’un médicament pour des raisons commerciales, cela devrait être notifié pour permettre à d’autres producteurs intéressés de poursuivre la production.</p>
<p class="contents">Deuxièmement, relocaliser la production des médicaments. C’est une mesure cruciale pour permettre un meilleur contrôle des chaînes d’approvisionnement. C’est aussi une mesure naturelle au vu des avantages reçus par les entreprises pharmaceutiques en Europe pour soutenir l’innovation. Ce serait donc juste que cela soit conditionné à la production en Europe.</p>
<p class="contents">Enfin, troisièmement, la création d’une infrastructure publique européenne des médicaments, dotée de capacités de recherche et de développement, mais également de capacités de production de médicaments essentiels, et ce, pour assurer un filet de sécurité pour l’approvisionnement des Européens. Nous ne pouvons pas nous reposer uniquement sur l’industrie pharmaceutique. Nous l’avons vu pendant la pandémie et nous devons agir en conséquence. Le Parlement a demandé à la Commission d’évaluer la faisabilité de créer une telle agence dans son rapport sur le COVID. Quand la Commission prévoit-elle de publier cette étude? Et la Commission prévoit-elle d’intégrer cet aspect dans sa communication fin octobre? </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-238-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197530.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:27:52&amp;playerEndTime=20231003-14:29:15" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Joanna Kopcińska, </span></span>  <span class="italic">w imieniu grupy ECR</span><span class="bold">.</span> – Panie Przewodniczący! Szanowna Pani Komisarz! Problem braku leków nie jest nowym wyzwaniem, a obecna debata nie jest pierwszą próbą wymiany poglądów, aby przeciwdziałać tej ryzykownej dla pacjentów sytuacji.</p>
<p class="contents">Wszystkie kraje członkowskie doświadczają problemów związanych z brakami leków. Brakuje leków kardiologicznych, leków stosowanych w chorobach układu oddechowego, antybiotyków oraz zaawansowanych leków stosowanych w chemioterapii i monoterapii chorób onkologicznych. Dodatkowym problemem stają się również leki pediatryczne, o które pytałam Komisję już w sierpniu bieżącego roku, na długo zanim została zaplanowana obecnie trwająca debata. </p>
<p class="contents">Jestem przekonana, że Komisja, której przysługuje inicjatywa, musi aktywnie zająć się bieżącymi problemami, nie składając ich rozwiązań tylko na karb obecnie procedowanej reformy prawa farmaceutycznego. Potrzebne są doraźne i natychmiastowe działania, przygotowane w ścisłej konsultacji z państwami członkowskimi i ich ekspertami narodowymi, które realnie włączałyby krajowe programy poszukiwań rozwiązań problemu braku leków w bardziej skoordynowane i ukierunkowane działania. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-239-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197483.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:29:22&amp;playerEndTime=20231003-14:30:28" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sylvia Limmer, </span></span>  <span class="italic">im Namen der ID-Fraktion</span><span class="bold">.</span> – Herr Präsident, Frau Kommissarin, verehrte Kollegen! Erstens: Laut Vertrag von Lissabon ist Gesundheit Sache der Mitgliedstaaten und hat nichts in den Händen einer EU-Kommission zu suchen, gegen die übrigens Ermittlungen laufen wegen erheblicher Unregelmäßigkeiten, womöglich sogar wegen Korruption, bei der Beschaffung der sogenannten Corona-Impfstoffe, und geschwärzte Verträge, zu teure, zu viele Impfstoffe und mehr Impftote als Corona-Tote sind das Resultat. Ich will keine Wiederholung!</p>
<p class="contents">Zweitens: Die rohstoff- und energieintensive Arzneimittelproduktion braucht eine starke chemische Industrie, aber deren Wettbewerbsfähigkeit zerstören Sie gerade mit Ihrem unsäglichen Grünen Deal. Bürokratie und Kostendruck − zum Beispiel durch Energiepreise − führt eben zur Abwanderung in Drittstaaten.</p>
<p class="contents">Also hören Sie auf zu jammern! Sie alle sind Mitverursacher, wenn es um Arzneimittelengpässe geht.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-240-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/23699.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:30:33&amp;playerEndTime=20231003-14:32:33" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Kateřina Konečná, </span></span>  <span class="italic">za skupinu The Left</span><span class="bold">.</span> – Pane předsedající, vážená paní komisařko, vážení kolegové, já se ptám: Co kromě diskuse se reálně udělalo pro to, aby naši občané měli dostupné byť jen základní léky? To, jaký postoj k tomu má Komise, se ukázalo, když její předsedkyni léková krize nestála ani za to, aby ji zmínila ve svém projevu o stavu Unie. Dovolte mi vás tedy nahradit, paní předsedkyně.</p>
<p class="contents">Stav ohledně nedostatku léků prakticky již dnes ve všech lékových skupinách je naprosto tragický. Dnes aby se člověk vůbec bál v Evropě onemocnět. Co se udělalo pro návrat výrobců API a generik zpět do EU, který Komise vyhlásila slavně už před třemi lety? Před třemi lety! Našly se na to peníze na úrovni členských států nebo snad EU? No nenašly. Zůstalo to prostě jen u vzletných plánů. Sliby, sliby a lidé trpí. Koneckonců nemusím chodit daleko, stačí vzpomenout na komedii s představením farmaceutického balíčku. Prostě na zbraně peníze najdete vždycky, když to zbraňový sektor potřebuje, ale vážená paní komisařko, tohle vám občané sečtou ve volbách. Ale co je horší? Díky tomu občané prostě v Evropě trpí, díky vaší neschopnosti. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-241-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96698.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:32:45&amp;playerEndTime=20231003-14:34:30" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Viktor Uspaskich (NI).</span></span>   – Gerbiamas pirmininke, pirmininkaujantis, gerbiami kolegos. Aš šiek tiek kitokiu rakursu. Aš pateikiau rezoliuciją dėl platesnės alternatyvios medicinos taikymo. Su visa pagarba žiūriu į tradicinės medicinos specialistus ir tikiu, kad jie padaro tai, kas kartais neįmanoma. Bet žvelgdamas iš savo šalies perspektyvos, matau, kad vyriausybė daro viską, kad tradicinės medicinos gydymo įstaigas vis labiau izoliuotų nuo savo pacientų. O susirgusiam žmogui patekti pas gydytoją tampa ne pasveikimo ir ramybės procedūra, o tikras žygdarbis ir naujos gal net ligos įgijimu. Tad primenu, kad alternatyvi medicina pacientą ne atstumia, o priima. Šioje medicinoje naudojamos tik natūralios medžiagos ar priemonės gydymui. Jos taikymas motyvuoja žmones vis labiau įsitraukti į savo sveikatos gerinimą, į sveiką gyvenimo būdą. Domėtis ir rūpintis savimi. Prisiimti didesnę atsakomybę už savo sveikatą. Visur, kur taikoma tokia metodika, pasiekta labai gerų rezultatų. Tad raginu Parlamentą ir Komisiją, kad ši idėja neužstrigtų (žodžiai, kurių nesigirdi) stalčiuose. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-242-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/38420.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:34:37&amp;playerEndTime=20231003-14:36:18" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Cristian-Silviu Buşoi, </span></span>  <span class="italic">on behalf of the PPE Group</span><span class="bold">.</span> – Mr President, issues related to availability, accessibility and affordability of medicines, as well as manufacturing dependency on third countries outside of the EU and disruptions or other situations along the whole supply chains, are routes for the shortages of medicines, and these circumstances is weakening our healthcare systems and hindering sustainable access to medicines for patients.</p>
<p class="contents">In this context, I would like to congratulate Commissioner Kyriakides and I welcome the European Commission proposal to review the pharmaceutical legislation and also to address in this revision a few of the main concerns as regards shortages.</p>
<p class="contents">But we need to do more than that. We need to be aware that we need to implement all the proposals in the pharma strategy. Therefore, we need financial instruments and to build on Europe's success of unlocking medicines for vulnerable patients. I think we need to strengthen global supply chains and keep them open, reduce import dependencies by diversifying sources of supply, creating incentives for R&amp;D and production in the Union, and last but not least, bringing back the production in our Union. There are many Member States that could make a change in this regard, and I would like to mention my country, Romania, where there is great potential to deploy production and manufacturing for medicines. We have seats, we have regions that could benefit economically, and we have also the necessary human resource in order to do that.</p>
<p class="contents">So, dear Commissioner, it is very important to find also the appropriate financial instruments at EU level and national level in order to fight efficiently against shortages.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-243-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197641.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:36:23&amp;playerEndTime=20231003-14:37:42" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sara Cerdas (S&amp;D).</span></span>   – Senhor Presidente, Comissária, Colegas, na União Europeia, nove em cada dez mortes são atribuídas a doenças não transmissíveis. Milhões de cidadãos europeus dependem de medicamentos essenciais. E, se não queremos sobrecarregar os sistemas de saúde que já estão em <span class="italic">stress</span>, importa garantir uma estratégia europeia que garanta o acesso a estes medicamentos a curto, a médio e a longo prazo. </p>
<p class="contents">Com a pandemia, nós aprendemos que a compra conjunta é uma ferramenta poderosa e pode ser implementada imediatamente para os medicamentos essenciais que estejam em escassez. A médio prazo, temos de reduzir a nossa dependência externa para a produção destes medicamentos, dado que a União Europeia tem a capacidade tanto científica como tecnológica para os produzir. </p>
<p class="contents">E, por último, a importância de diversificarmos os locais de produção nos vários países da União Europeia e garantir cadeias de abastecimento mais fortes e mais resilientes a longo prazo. </p>
<p class="contents">Saúdo, assim, a proposta da Comissão de um mecanismo de identificação dos pontos de rutura e de estabelecer mecanismos de resposta à altura. A regulamentação farmacêutica é bem-vinda e as negociações devem acautelar estas propostas para uma verdadeira União Europeia para a Saúde. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-244-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/4253.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:37:48&amp;playerEndTime=20231003-14:39:07" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Frédérique Ries (Renew).</span></span>   – Monsieur le Président, Madame la Commissaire, 3 000 médicaments au total ont manqué à l'appel en Belgique l'année dernière, des molécules les plus banales, le paracétamol, à celles qui sauvent des vies. On frôle ici l'urgence sanitaire. Les pénuries sont endémiques et la tendance est alarmante dans trois États membres sur quatre. La communication que vous venez d'annoncer, Madame la Commissaire, sur les mesures contre les pénuries va évidemment dans la bonne direction, notamment pour les achats groupés. L'HERA doit y prendre toute sa part, vous connaissez notre position, nous ne cessons de la répéter. </p>
<p class="contents">Mais on doit aller plus loin, bien évidemment aussi avec une véritable stratégie industrielle. L'Europe est largement dépendante des substances actives venant d'Asie et une sur deux affiche moins de cinq fabricants dans le monde. Une politique industrielle donc, qui est nécessaire, c'est ce que vous demandez en mai dernier et à l'initiative de la Belgique 21 États membres en appelant à un acte européen pour les médicaments critiques. Un véritable mécanisme aussi de solidarité entre les États membres. </p>
<p class="contents">Ce que je viens de dire ici en une minute, quasiment mot pour mot, nous sommes très nombreux ici à le répéter depuis cinq ans, depuis six ans. Alors, il est urgent, Madame la Commissaire, maintenant, de passer de l'incantation à l'action.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-245-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96743.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:39:14&amp;playerEndTime=20231003-14:41:04" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Michèle Rivasi (Verts/ALE).</span></span>   – Monsieur le Président, Madame la Commissaire, on se retrouve sur le problème de la pénurie des médicaments et l'autonomie stratégique en matière de soins de santé dans l'Union européenne. Alors, cela fait quand même plus de dix ans que le problème est devenu chronique. Tout à l'heure, ma collègue parlait de trois mille médicaments en pénurie en Belgique, il y en a plus de trois mille aussi en Italie. </p>
<p class="contents">Et que fait l'Europe? C'est vrai que, et là je suis d'accord avec vous, c'est de la compétence de l'Europe. Alors qu'est-ce qu'on a fait? On a augmenté les compétences de l'Agence européenne des médicaments en disant c'est à vous à faire un catalogue de médicaments essentiels. Eh bien, écoutez, j'ai regardé sur leur site, on a entre 20 et 40 médicaments essentiels. On a fait des groupes de travail, le SPOC, le MSSG, pour essayer de voir l'offre et la demande, mais on n'a pas fait grand-chose. </p>
<p class="contents">Alors il faut ouvrir la boîte à outils. Dans la boîte à outils, c'est vrai qu'il peut y avoir des incitations financières, vous avez raison. Mais quand je regarde les labos, qu'est-ce qu'ils demandent les labos? Ils disent qu'il faut augmenter le prix des médicaments. Et pour les médicaments qui ne sont plus couverts par rapport à un brevet, eh bien qu'est-ce qu'ils veulent? Qu'on augmente le prix. Et ça coûte très cher au niveau de la sécurité sociale. </p>
<p class="contents">On peut avoir aussi ce qu'on appelle des notifications obligatoires, c'est à dire, quand un labo décide de ne plus fabriquer un médicament, il faut qu'il en informe une entreprise et qu'il lui donne les autorisations de mise sur le marché. </p>
<p class="contents">Et dernière chose, il faut faire un établissement public. Ils ne veulent pas le fabriquer. Très bien. Eh bien on fait un établissement public, ça existe aux États-Unis, Madame la Commissaire, ça s'appelle Civica. Et je vous assure qu'il serait bien que vous y alliez parce que c'est très intéressant, ils fabriquent des médicaments.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-246-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/204414.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:41:14&amp;playerEndTime=20231003-14:42:34" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Margarita de la Pisa Carrión (ECR).</span></span>   – Señor presidente, señora comisaria, señorías, la inquietud de los padres fundadores de la Unión Europea fue conciliar la paz a través de acuerdos que garantizaran el suministro de energía y materias primas. Pero hoy vemos como nuestro mercado único no está dando la respuesta necesaria por estrategias o legislaciones ideologizadas que han comprometido nuestra competitividad. Dependemos de bienes básicos como los principios activos y los componentes de medicamentos. Dependemos de terceros países como la India y China. Dependemos de tratamientos contra el cáncer, antibióticos para niños o para el diagnóstico, como el yodo. Se ponen en riesgo la salud y la vida de los pacientes si se nos limita o corta el suministro. No sé si se dan cuenta del daño que nos pueden provocar. Es un problema de seguridad. </p>
<p class="contents">Hoy la Agencia Española de Medicamentos informa de 954 medicamentos con problemas de suministro. Muchos, sin alternativa. No se resolverá este grave problema si no se corrigen las legislaciones que perjudican a nuestra industria. Y, la verdad, no vemos intención de hacerlo. La Comisión ha presentado una propuesta de legislación farmacéutica que desincentiva por completo la innovación en nuestro espacio. Corrijamos este rumbo y luchemos por la seguridad y la salud que todos merecemos. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-247-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197616.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:42:39&amp;playerEndTime=20231003-14:43:38" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Rosanna Conte (ID).</span></span>   – Signor Presidente, onorevoli colleghi, non abbiamo abbastanza farmaci nell'Unione europea. Ormai da vent'anni a pagare le spese di queste carenze strutturali sono i cittadini, che solo in Italia hanno sofferto la totale assenza di quasi 900 farmaci lo scorso inverno. Sono numeri che devono farci riflettere non solo sulla carenza di farmaci, ma anche sulla dipendenza da Stati terzi.</p>
<p class="contents">È per questo che diversificare la produzione non basta. Bisogna soprattutto sostenere al più presto una nuova politica industriale che concentri in Europa la realizzazione dei principi attivi di cui abbiamo bisogno. La speranza è che queste soluzioni arrivino dalla prossima strategia farmaceutica, da cui tutti ci aspettiamo un deciso cambio di approccio.</p>
<p class="contents">Con la stagione invernale alle porte non possiamo più permetterci di ripetere gli stessi errori del passato e dipendere ancora da altri, specialmente quando si parla della salute dei nostri cittadini.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-248-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96820.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:43:42&amp;playerEndTime=20231003-14:44:52" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marisa Matias (The Left).</span></span>   – Senhor Presidente, Senhora Comissária, o problema da escassez de medicamentos só deixará de ser um problema quando o acesso aos cuidados de saúde for colocado à frente do negócio, dos interesses e do lucro das farmacêuticas. Não bastam pensos rápidos na legislação europeia. Já sabemos o que acontece com esses: mais cedo ou mais tarde acabam por cair e expor as feridas do sistema. </p>
<p class="contents">Do que nós precisamos é de mudar de abordagem: precisamos de sistemas públicos e universais de saúde, precisamos de um controlo público sobre a produção de medicamentos, não só para prevenir a escassez, mas também para garantir que todas e todos os que deles necessitam têm acesso aos medicamentos, independentemente do seu rendimento ou de terem ou não terem doenças raras. </p>
<p class="contents">E tudo isto é ainda mais urgente no momento de crise económica que vivemos, em que as pessoas têm de escolher entre pagar a casa, comer ou comprar medicamentos. Quando enfrentamos um problema de escassez de medicamentos nesta região do mundo, na região mais rica do mundo, é porque claramente o negócio foi posto à frente da saúde pública. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-249-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/27714.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:44:59&amp;playerEndTime=20231003-14:46:19" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Edina Tóth (NI).</span></span>   – Elnök Úr! Két nap, két magyar Nobel-díj. A beszédemet azzal szeretném kezdeni, hogy sok szeretettel gratulálok Karikó Katalinnak és Krausz Ferencnek a rangos elismeréshez. </p>
<p class="contents">Az elhúzódó gyógyszerhiány veszélybe sodorja a betegeket, és óriási kihívást jelent a nemzeti egészségügyi rendszerek számára. Mivel az egyik legsúlyosabb probléma az, hogy a gyógyszergyártáshoz használt hatóanyagok nagy része a Távol-Keleten, Kínában és Indiában készül, ezért úgy gondolom, hogy az EU gyártási és ellátási folyamatainak megerősítésére kiemelt figyelmet kell fordítanunk.</p>
<p class="contents">Ez azonban nem lehetséges az Európai Unió területén már meglévő gyógyszergyárak gyártási kapacitásának növelése és új gyártók bevonása nélkül, amely során elengedhetetlen az egyenlő földrajzi elosztás érvényesülése. A közép- és kelet-európai régió nem lehet az EU mostohagyereke, és fontos, hogy az itt található korszerű gyártókapacitásokat is bevonjuk a termelés növekedése és a minket sújtó gyógyszerhiány megfékezése érdekében.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-250-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197692.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:46:38&amp;playerEndTime=20231003-14:48:45" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Στέλιος Κυμπουρόπουλος (PPE).</span></span>   – Κύριε Πρόεδρε, αγαπητή κύρια επίτροπε Κυριακίδη, αγαπητοί κύριοι συνάδελφοι, τα τελευταία χρόνια έχουμε δει μια ανησυχητική αύξηση της συχνότητας των ελλείψεων φαρμάκων σε ολόκληρη την Ευρωπαϊκή Ένωση, την ίδια στιγμή που η εξάρτησή μας από μικρό αριθμό παρασκευαστών ευρισκόμενων εκτός της Ένωσης γίνεται, δυστυχώς ακόμα μεγαλύτερη. Είναι, λοιπόν, αδιαμφισβήτητα στρατηγικής σημασίας η αύξηση της στρατηγικής αυτονομίας της Ευρωπαϊκής Ένωσης στον χώρο του φαρμάκου και η απεξάρτησή της για πρώτες ύλες από τρίτες χώρες. </p>
<p class="contents">Στην πρότασή της για την αναθεώρηση της φαρμακευτικής νομοθεσίας, η Επιτροπή, για την αντιμετώπιση των ελλείψεων, ζητά έναν κατάλογο κρίσιμων φαρμάκων της ΕΕ, ενισχυμένη λογοδοσία και αυξημένο ρόλο του ENL στην παρακολούθηση και τον συντονισμό των προμηθειών. Για να αντιμετωπιστούν, ωστόσο, αποτελεσματικά οι ελλείψεις και να εξασφαλιστεί η στρατηγική αυτονομίας της ΕΕ, κλειδί αποτελεί η ενίσχυση της έρευνας και της εσωτερικής παραγωγής, ενώ ένα σύστημα παρακολούθησης, κοινής χρήσης περισσότερων συγκεντρωτικών δεδομένων και άμεσης ενημέρωσης των ελλείψεων ή της μειωμένης διαθεσιμότητας στα κράτη μέλη, μπορεί να αντιμετωπίσει το πρόβλημα στη ρίζα του. </p>
<p class="contents">Για τον σκοπό αυτό, πρότυπο πρέπει να αποτελεί η καινοτομία της ελληνικής κυβέρνησης με τη δημιουργία ενός online μηχανισμού, με τον οποίο δημόσιοι και ιδιωτικοί φορείς, πολίτες και επαγγελματίες στον τομέα της υγείας θα μπορούν να ενημερώνονται άμεσα, εύκολα και με διαφανή τρόπο για σκευάσματα που δεν είναι διαθέσιμα. Έτσι, θα επιταχυνθεί η πρόσβαση των ασθενών σε θεραπείες και θα καταστούν τελικά βιώσιμα τα συστήματα υγείας.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-251-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/23868.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:49:02&amp;playerEndTime=20231003-14:50:38" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Monika Beňová (S&amp;D).</span></span>   – Pani komisárka, neobmedzený prístup k cenovo dostupným liekom pre našich občanov pokladám za prioritu pre záver tohto legislatívneho obdobia. Je škoda, že sa tomu venujeme až v posledných mesiacoch. Pre občanov členských štátov Európskej únie je prístup k liekom existenčne dôležitá téma a ako spravodajkyňa pre revíziu všeobecných pravidiel o liekoch chcem spraviť všetko preto, aby sme raz a navždy zaviedli dlhodobé riešenia na predchádzanie nedostatku liekov.</p>
<p class="contents">Slovensko je bohužiaľ dlhodobo na chvoste Európskej únie v dĺžke uvádzania inovatívnych liekov na slovenský trh. Slovenskí občania musia čakať v priemere 2 roky na už schválený liek, ktorý je bezpečný a efektívny.</p>
<p class="contents">Európska únia môže, a musí, urobiť viac v spolupráci s národnými inštitúciami, aby zabezpečila, že členské štáty, ako je napríklad Slovensko, budú mať prístup k inovatívnym liekom pre deti, pre onkologických pacientov alebo pacientov so zriedkavými chorobami vrátane generických liekov.</p>
<p class="contents">Rovnako vyzývam farmaceutický priemysel a inštitúcie Únie a národné orgány, aby zasiahli pri nekontrolovanom reexporte liekov. Pretože nečinnosť vedie k zvyšovaniu cien, ale hlavne k rozšíreniu nedostatku, či už v členských štátoch Európskej únie, iných, alebo aj u nás na Slovensku.</p>
<p class="contents">Hovorím to aj ako mama. Chýbajú nám lieky pre deti, takže musíme s tým niečo urobiť. Lieky nemajú byť na kšeftovanie. Majú byť na to, aby slúžili ľuďom v Európskej únii.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-252-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/247122.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:50:46&amp;playerEndTime=20231003-14:52:16" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Catherine Amalric (Renew).</span></span>   – Monsieur le Président, Madame la Commissaire, chers collègues, nous avons tous pris conscience, partout en Europe, que le modèle actuel ne nous garantit plus l’accès aux médicaments, mêmes essentiels, en toute situation. Dans l’objectif de l’autonomie stratégique que vous soutenez, Madame la Commissaire, une loi européenne sur les médicaments critiques servirait notre ambition de préserver, dans une égalité de droits, chaque Européenne, chaque Européen d’une perte de chances face à la maladie par manque de médicaments.</p>
<p class="contents">Cette loi est à élaborer en lien étroit avec l’importante révision de la législation pharmaceutique européenne que nous entamons aujourd’hui. Ainsi, avec un portail européen de traçabilité des flux de médicaments apte à permettre, en cas de pénurie, une répartition solidaire des stocks entre les États membres, par des achats conjoints négociés à l’échelle européenne, mais aussi par la relocalisation de principes actifs critiques en Europe, tout en allant vers une production décarbonée en cohérence avec le pacte vert, par l’harmonisation des procédures d’essais cliniques et de mise sur le marché, par la multiplication de «bio clusters», d’écosystèmes d’innovation en Europe et un soutien fort à l’innovation et à la recherche, ces textes devraient construire une nouvelle politique du médicament attractive pour une Europe souveraine, solidaire et durable. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-253-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/58766.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:52:25&amp;playerEndTime=20231003-14:53:47" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nicolae Ştefănuță (Verts/ALE).</span></span>   – Domnule președinte, doamna comisară, doresc mai întâi să transmit un mesaj Guvernului României din partea a 782 de farmacii independente care cer să le fie facturile restante plătite. Bruxelles, avem o mare problemă: nu toți pacienții sunt tratați la fel. Un doctor din România așteaptă în medie doi ani mai mult decât un medic din Germania pentru a putea prescrie cel mai nou și cel mai bun medicament de pe piață. Mă gândesc la prietenii mei, la Ion și la Carmen, care sunt pensionari în București, și nu vreau să știu că au nevoie de ceva și noi nu le dăm în timp util acel medicament. Salvarea unei vieți în Europa nu ar trebui să fie o loterie în funcție de unde te-ai născut în Europa. </p>
<p class="contents">Doamna Kyriakides, în aprilie ați spus că pacienții din statele occidentale au acces în măsură de 90 % la cele mai noi și cele mai bune medicamente, pe când în Est abia 10 %. Ei bine, aveți competențe, sunteți comisară pe sănătate, aveți competențe și în privința pieței unice. Ce ați făcut? Ce veți face așa încât toți să aibă acces la aceleași medicamente în același timp? Haideți să facem Europa egală din nou. Haideți să o facem sănătoasă din nou. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-254-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124884.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:53:53&amp;playerEndTime=20231003-14:55:16" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Kosma Złotowski (ECR).</span></span>   – Obecnie aktywne składniki farmaceutyczne stosowane w lekach produkowanych w Unii Europejskiej pochodzą głównie z Chin i Indii. Także znaczna część wszystkich leków sprzedawanych w Europie pochodzi z wyżej wymienionych krajów, co wydłuża łańcuchy dostaw i wywołuje nagłe niedobory oraz wzrosty cen w sytuacji problemów z transportem. Każdy taki kryzys to poważne zagrożenie dla zdrowia publicznego. Nadal nie doczekaliśmy się odpowiednich inicjatyw na szczeblu unijnym, które zachęcałyby producentów do inwestowania w produkcję API w Europie. </p>
<p class="contents">Potrzebujemy dedykowanych rozwiązań, takich jak w przypadku rynku mikroprocesorów. Mamy i silny sektor farmaceutyczny, także w Polsce, który byłby gotów podołać temu zadaniu przy odpowiednim wsparciu. Czy Komisja planuje przyjęcie odrębnej strategii relokacji produkcji API do Unii Europejskiej uwzględniającej zmiany przepisów, uelastycznienie norm środowiskowych i środki finansowe dla firm farmaceutycznych pragnących produkować aktywne składniki farmaceutyczne w Europie? </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-255-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/136236.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:55:22&amp;playerEndTime=20231003-14:56:35" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">João Pimenta Lopes (The Left).</span></span>   – Senhor Presidente, a dramática realidade de escassez de medicamentos, cada vez mais frequente, é um problema, em primeiro lugar, para o doente que vê comprometido o seu tratamento. </p>
<p class="contents">Trata-se de uma situação indissociável da crescente concentração do setor farmacêutico, indústria que atua não em prol da saúde pública, mas antes da acumulação de lucros cada vez maiores, mesmo que por via da especulação, de restrições à produção ou dos elevados custos dos medicamentos. </p>
<p class="contents">A COVID-19 espelhou bem esta realidade, como o conluio das instituições da União Europeia com as multinacionais farmacêuticas. É precisa outra política para o medicamento, garantindo a soberania e independência dos Estados e que as patentes não sejam uma barreira à produção e ao abastecimento.</p>
<p class="contents">Em Portugal, são necessários mais meios para o Laboratório Nacional do Medicamento para garantir a produção dos medicamentos de maior utilização em rutura ou com falhas de abastecimento, alargando a produção de medicamentos genéricos, contribuindo para o autoaprovisionamento, reservas e medicamentos mais baratos, gratuitos até, para maiores de 65 anos, para quem tenha carências económicas ou para os doentes crónicos. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-256-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197734.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:56:40&amp;playerEndTime=20231003-14:57:54" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Λευτέρης Νικολάου-Αλαβάνος (NI).</span></span>   – Κύριε Πρόεδρε, παρά τα εκατομμύρια των νεκρών από την πανδημία στην Ευρώπη, δεν ιδρώνει το αυτί της Ευρωπαϊκής Ένωσης και των κυβερνήσεών της. Πυξίδα σας έχετε το φάρμακο-εμπόρευμα, τα νοσοκομεία που λειτουργούν με όρους πληρότητας —λες και είναι ξενοδοχεία—, ενώ σήμερα μπορεί να υπάρξει ενιαίο, αποκλειστικά κρατικό σύστημα υγείας με κριτήριο τη δωρεάν πρόληψη, περίθαλψη και αποκατάσταση της υγείας του λαού, όπως και κάλυψη των αναγκών για φάρμακα όταν τα χρειάζεται ο λαός, τόσο σε συνθήκες αυξημένης ζήτησης όσο και σε έκτακτες συνθήκες. </p>
<p class="contents">Αυτές οι υπαρκτές δυνατότητες προσκρούουν στην ευρωενωσιακή στρατηγική εμπορευματοποίησης του δημόσιου συστήματος υγείας, στην κερδοφορία των ιδιωτικών μαγαζιών υγείας και των φαρμακευτικών κολοσσών που κατέχουν τις πατέντες, ανταγωνίζονται σκληρά μεταξύ τους, κερδοσκοπώντας σε βάρος της υγείας του λαού. Οι εργαζόμενοι δεν πρέπει να επιτρέψουν να γίνεται η ζωή τους θυσία στο καπιταλιστικό κέρδος. Να παλέψουν για κατάργηση των πατεντών, παράλληλων εξαγωγών φαρμάκων, για δωρεάν φάρμακα τη στιγμή που τα χρειάζονται, για σύγχρονο, εξοπλισμένο, στελεχωμένο δημόσιο σύστημα υγείας, χωρίς επιχειρηματική δράση, για προσωπικό με μόνιμη σταθερή δουλειά και μισθούς με βάση τις σύγχρονες ανάγκες.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-257-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197648.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:58:02&amp;playerEndTime=20231003-14:59:24" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Alexander Bernhuber (PPE).</span></span>   – Herr Präsident, sehr geehrte Frau Kommissarin! Über 50 % − ja, Sie haben richtig gehört: mehr als die Hälfte – der Medikamente, die wir dringend benötigen, sind einfach nicht verfügbar. Medikamente zur Krebstherapie, Impfstoffe und Arzneimittel zur Behandlung von schweren Nervenkrankheiten wie Epilepsie, Parkinson sind Mangelware.</p>
<p class="contents">Das ist einfach inakzeptabel, und es geht so nicht weiter. Wir müssen wirklich unbedingt, wenn es darum geht, die Abhängigkeit speziell von Drittländern – China, Indien sind hier hervorzuheben − zu verringern, stark eingreifen und handeln. Es braucht endlich wieder ein klares Bekenntnis zur Produktion von Arzneimitteln in Europa.</p>
<p class="contents">Nur ein kleines Beispiel: In meinem Heimatland Österreich sind derzeit 577 Medikamente nicht oder nur schwer verfügbar und eingeschränkt erhältlich, speziell Arzneimittel für Kinder. Hier brauchen wir unbedingt einen gemeinsamen Ansatz.</p>
<p class="contents">Frau Kommissarin, hier sind wir jetzt wirklich gemeinsam am Zug: Schaffen wir endlich Bedingungen, unter denen wir die Produktion von Arzneimitteln wieder zurück nach Europa holen können, damit diesen Lieferengpässen, die wir derzeit über Europa hinweg haben, endlich entgegengewirkt wird.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-258-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197446.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-14:59:29&amp;playerEndTime=20231003-15:00:42" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Milan Brglez (S&amp;D).</span></span>   – Gospod predsednik, spoštovana komisarka, kolegice in kolegi!</p>
<p class="contents">Motnje v preskrbi z zdravili so zaskrbljujoče, postajajo kar običajne v Evropski uniji. Z administrativnimi ovirami in težavami v proizvodnji in pri uvozu se srečujemo predvsem na manjših trgih, kot je recimo slovenski, kjer primanjkuje 300 zdravil.</p>
<p class="contents">Posebej problematično je pomanjkanje osnovnih antibiotikov in zdravil za zdravljenje redkih bolezni in bolezni najmlajših. Ker je nedopustno, da tržni mehanizem nadvlada nad dostopom do osnovnih zdravstvenih storitev, se sam zavzemam za podporo proizvodnji zdravil v Evropski uniji ter skupna javna naročila za zdravila za otroke, starejše in kronično bolne.</p>
<p class="contents">Menim, da imamo na ravni Evropske unije primerne mehanizme. Za ta namen smo recimo dali dodatna pooblastila Evropski agenciji za zdravila in ustanovili Evropski organ za pripravljenost in odzivanje na izredne zdravstvene razmere.</p>
<p class="contents">Zato jih pozivam, da v okviru svojih pristojnosti storijo vse, kar je treba, ter s tem prispevajo k družbeni odpornosti in strateški avtonomiji zdravstvene oskrbe v Evropski uniji.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-259-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197711.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-15:00:47&amp;playerEndTime=20231003-15:02:39" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Dolors Montserrat (PPE).</span></span>   – Señor presidente, el desabastecimiento de fármacos es un grave problema en toda Europa, que está repercutiendo directamente en la salud de los europeos. Por ejemplo, en España hay escasez de más de 900 fármacos. Por eso, denunciamos que la Unión Europea no haya puesto en marcha ya una política de apoyo para la producción de principios activos y de medicamentos, un ámbito que quiero recordar que ya está incluido en la Estrategia Industrial como ámbito clave de dependencia. </p>
<p class="contents">Dentro de esta Estrategia Industrial, la Comisión está apoyando, por ejemplo, la producción de materias primas, baterías, hidrógeno limpio y semiconductores, así como la digitalización. Todos ellos son ámbitos estratégicos, pero también lo es la producción de activos farmacéuticos y de medicamentos. </p>
<p class="contents">Así pues, seguimos dependiendo de terceros países para adquirir los principios activos. Esto significa que tenemos escasez, que tenemos desabastecimiento y, por tanto, que somos más vulnerables. Y, sobre todo, los más vulnerables son los más pequeños en Europa, nuestros hijos. </p>
<p class="contents">Sabemos que la demanda de medicamentos seguirá aumentando. ¿Por qué? Por el envejecimiento de nuestra población, y también debido al aumento de las enfermedades crónicas. Y por ello no podemos perder más tiempo. Exigimos medidas inmediatas y también que las incluyamos en el paquete legislativo farmacéutico. Porque necesitamos un sector farmacéutico europeo fuerte, competitivo y, sobre todo, que sea considerado estratégico. </p>
<p class="contents">Por eso, desde el Parlamento y todos sus grupos políticos, hemos pedido a la Comisión que presente con urgencia medidas para garantizar la producción de medicamentos. Aplaudo la próxima Comunicación que presentará la Comisión, pero es muy importante incluir esas medidas en el paquete legislativo. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-260-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197657.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-15:02:45&amp;playerEndTime=20231003-15:04:14" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Tudor Ciuhodaru (S&amp;D).</span></span>   – Domnule președinte, vreau ca toți pacienții din România să beneficieze de medicamente ieftine și suntem pe un teren minat. Peste 3 000 de medicamente esențiale au dispărut din farmacii și multe dintre ele sunt esențiale, care salvează vieți, iar este pentru prima dată când la nivel european, amoxicilina și paracetamolul nu au fost disponibile. </p>
<p class="contents">Accesibilitate înseamnă disponibilitate și preț. Demersul meu de astăzi este legat de o Uniune Europeană a sănătății și în acest domeniu, iar cele cinci obiective prioritare pentru mine, pe care le-am depus deja ca prim-vicepreședinte al Comisiei de Sănătate, înseamnă o veritabilă revoluție în ceea ce înseamnă politica farmaceutică și fiecare cetățean vulnerabil din această Europă să beneficieze de medicamente ieftine atunci când are nevoie. </p>
<p class="contents">Ele sunt practic crearea unei liste de medicamente esențiale, standarde europene de calitate în sănătate, o strategie unitară de producție bazată inclusiv pe resuscitarea capacităților de producție existente. Vă invit, doamna comisară, să susțineți Institutul „Cantacuzino” din România. Poate deveni oricând o soluție la problemele strategice ale Europei. </p>
<p class="contents">Pe de altă parte, vorbesc despre reducerea sau chiar eliminarea taxelor pentru medicamente generice. Deja le-am susținut în fața doamnei comisare, iar pe de altă parte, o farmacie de urgență, pe modelul „rescEU”, în care producătorii să fie obligați să aibă 10 % din vânzările anuale pe stoc, ca să poată răspunde atunci când vorbim despre solicitări crescute sau lanțuri dificile de aprovizionare. Sănătatea se tratează cu soluții concrete și sper să mă susțineți și în acest demers. Vă invit, doamna comisară, să vedeți și Institutul „Cantacuzino” din România. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-261-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/240478.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-15:04:21&amp;playerEndTime=20231003-15:05:37" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Beatrice Covassi (S&amp;D).</span></span>   – Signor Presidente, onorevoli colleghi, signora Commissaria, questo dibattito lo dice chiaramente: l'allarme carenza farmaci è sempre più acuto in Europa; solo in Italia mancano all'appello più di 3 000 medicinali. Un fenomeno ormai strutturale, con carenze aumentate del 60 % negli ultimi anni, e che richiede risposte urgenti, a partire dalla riduzione della dipendenza da pochi produttori extra europei per i principi attivi necessari a fabbricare i medicinali.</p>
<p class="contents">Ma attenuare le carenze non basta. Dobbiamo puntare alla prevenzione con un coordinamento europeo tra i diversi anelli della catena distributiva e azioni per garantire ai nostri cittadini e alle nostre cittadine sempre le migliori cure.</p>
<p class="contents">Per questo chiedo a gran voce alla Commissione europea di attuare iniziative e strumenti, anche finanziari, che favoriscano la produzione europea di medicinali essenziali, principi attivi e trattamenti innovativi.</p>
<p class="contents">Colleghi, la risposta comune alla pandemia ci ha insegnato l'importanza dei sistemi sanitari, ma in troppi, a partire dal governo del mio paese, sembrano aver dimenticato, ancora una volta sacrificando la spesa sanitaria. Allora, che il diritto alla salute resti la nostra priorità e lavoriamo insieme da oggi per avere un'Unione europea della salute.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-262-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/5729.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-15:05:42&amp;playerEndTime=20231003-15:07:01" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Kathleen Van Brempt (S&amp;D).</span></span>   – Voorzitter, mevrouw de commissaris, twintig jaar geleden produceerde de EU de helft van haar eigen geneesmiddelen en vandaag de dag is dat nog maar een kwart. Voor verschillende medicijnen die we heel erg nodig hebben, zijn we voor 100 % afhankelijk geworden van China en India. We hebben vandaag de dag op Europese bodem nog maar één fabriek die antibiotica produceert en die waren we bijna kwijt.</p>
<p class="contents">Stelt u zich voor dat er morgen een superbacterie opduikt en dat Europa zelf niet in staat is om antibiotica te produceren, zodat we dus in volle pandemie moeten wachten op een levering van – jawel – China. Dat doet wel een belletje rinkelen, want in de pandemie hebben we moeten wachten op de mondmaskers. En als we één ding geleerd hebben uit die covidpandemie, dan is het dat de Europese Unie zich beter moet leren wapenen tegen gezondheidsrisico’s en pandemieën. Dat doen we dus níét als we geen afdoende antwoord hebben op een medicijnentekort.</p>
<p class="contents">Ik heb een voorstel, mevrouw de commissaris. U hebt een mededeling aangekondigd. Wel, België heeft de “Critical Medicines Act” gelanceerd, gesteund in de Raad en gesteund in het Parlement en zal dat met het Belgische voorzitterschap ook extra onderstrepen. Ik hoop dat u dat opneemt in uw mededeling.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-263-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents" align="center"><span class="bold">IN THE CHAIR: ROBERTS ZĪLE </span><br /><span class="italic">Vice-President</span></p>
<p class="contents"><span class="italic">Catch-the-eye procedure</span></p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-264-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124785.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-15:07:15&amp;playerEndTime=20231003-15:08:37" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Maria Grapini (S&amp;D).</span></span>   – Domnule președinte, doamna comisară, stimați colegi, sigur, discutăm o situație care ține de viața oamenilor. Hrana, apa, medicamentele asigură viața oamenilor până la urmă. </p>
<p class="contents">Nu pot să nu spun că sunt de acord cu ce ați prezentat, doamna comisară, dar întrebarea mea firească este: eu sunt în Parlament din 2014, de ce o listă a medicamentelor critice pe care spuneți că vreți să o faceți, o facem pentru prima dată? Acum am aflat că sănătatea este prioritate? E bine că o facem. Problema e: când ajungem să avem acele stocuri de medicamente esențiale pentru toți cetățenii? Tot dumneavoastră ați spus că indiferent unde trăiește un cetățean, și așa este, trebuie să aibă acces la medicamente. </p>
<p class="contents">În țara mea, să știți că primesc petiții săptămânal, nu lunar. Lipsesc medicamentele pentru epilepsie, medicamentele pentru tiroidă, medicamentele pentru cancer. Medicii din România trebuie să aleagă cui dau un tratament și pe cine abandonează. Este cumplit ca un medic să decidă soarta, din motiv de penurie de medicamente. </p>
<p class="contents">Spuneați că avem măsuri, dar iată, 60 % a crescut penuria. Ce facem concret? Pentru că lucrurile trebuie rezolvate acum și nu în viitor, pentru că viața oamenilor nu așteaptă să rezolvăm noi problemele. Sănătatea este prioritate. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-265-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197786.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-15:08:47&amp;playerEndTime=20231003-15:09:58" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Susanna Ceccardi (ID).</span></span>   – Signor Presidente, onorevoli colleghi, si parla spesso di sovranità energetica e di sovranità alimentare, ma dovremmo parlare di più di sovranità farmaceutica, un settore trainante per le economie nazionali ed europee.</p>
<p class="contents">La maggior parte dei principi attivi, come è stato detto, è prodotta in Cina e in India. Questo dato è allarmante per la nostra sicurezza farmaceutica. Se avessimo una crisi mondiale, per esempio, molti dei farmaci salvavita che conosciamo, per esempio quelli antidiabetici, non potrebbero salvare la vita a milioni di persone in Europa. </p>
<p class="contents">E purtroppo negli ultimi vent'anni l'Unione europea ha perso il 25 % dei finanziamenti, perché altri paesi hanno investito di più: l'Arabia Saudita, la Cina e gli USA.</p>
<p class="contents">La proposta della Commissione europea svantaggia gli Stati comunitari perché rischia di aumentare le delocalizzazioni. Quindi no alle delocalizzazioni. Proteggiamo la proprietà intellettuale e gli investimenti.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-266-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/187917.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-15:10:06&amp;playerEndTime=20231003-15:11:27" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marc Botenga (The Left).</span></span>   – Monsieur le Président, Madame la Commissaire, des milliers de médicaments manquent dans l’Union européenne, pays par pays, des médicaments qui peuvent sauver des vies, et les médicaments disponibles sont souvent trop chers. Les États paient des prix absolument dingues. Mais il faut aussi oser dire pourquoi c’est le cas. L’explication, la raison est claire: vous avez décidé de laisser tout le pouvoir aux grandes multinationales pharmaceutiques. Ce sont elles qui décident quoi produire, quand produire, combien produire et à quel prix vendre. Certaines d’entre elles ont même le numéro personnel de Mme von der Leyen.</p>
<p class="contents">Alors, si vous êtes sérieuse par rapport au besoin d’avoir des médicaments accessibles, abordables, il faut faire deux choses. Tout d’abord, arrêtez de donner de l’argent gratuit sans condition à ces multinationales. Mettons des conditions claires. Demandons que le médicament soit effectivement accessible, effectivement abordable. Deuxièmement, développons une infrastructure, une entreprise publique pour la recherche et le développement et pour la production de médicaments. Vous savez, cela existe au Canada, aux États-Unis et même à Cuba, petit pays sous blocus qui a réussi à développer des vaccins. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-267-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-15:11:19&amp;playerEndTime=20231003-15:11:45" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><span class="italic">(End of catch-the-eye procedure)</span></p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-268-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/doceo/data/img/photo_generic.gif" align="right" width="50" height="63" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-15:11:40&amp;playerEndTime=20231003-15:19:23" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Stella Kyriakides,</span></span>   <span class="italic">Member of the Commission</span><span class="bold">.</span> – Mr President, honourable Members, this has indeed been a very interesting debate on many points that have been raised here. I believe that we find ourselves on the same page, but I also believe that this is an opportunity for myself, standing in front of you, to put forward again some of the points that we have frequently debated upon and why we are all discussing this today.</p>
<p class="contents">It was in fact, I think MEP Socal, who started off today saying that there should be no first and second class citizens in access to medicines. One of your other colleagues – and in many ways you have all said this – said that we all need to work together to address shortages, but also to make sure that not only do we address shortages, but patients have access to affordable medicines and have access to innovation.</p>
<p class="contents">So in order to do this, I have said from the beginning we need to have all players on board. We need to have industry on board. We need to have supply chain holders or stakeholders on board. We need to have Member States and their health systems on board. And, of course, we need to have all the EU and the institutions on board.</p>
<p class="contents">Now in the pharmaceutical reform that we have put forward – and this needs to be absolutely clear – we are looking at strengthening our pharmaceutical sector in Europe and to keep it as a global frontrunner and keep it as a frontrunner in innovation. So I will not agree with the statement that I have heard saying that our reform will be discouraging innovation. I believe that we can collectively feel proud of what we have achieved in the last three or four years, in putting together a strong European health Union.</p>
<p class="contents">Let’s just remind ourselves what we have done together and with your support. And I think that this always needs to be said. We have extended the mandate of the European Medicines Agency, which allows them really to be able to be proactive. Now in the area also of shortages, we’ve created a new agency or authority HERA, which comes to support the efforts that we are doing. And we have put forward a new proposal on a pharma reform. </p>
<p class="contents">Now, I mentioned in my opening remarks that we are coming forward with a communication. I wanted to just say in two seconds what this will be, because it is important that you’re aware of this. This is going to be a toolbox of actions which will be enhancing the availability and security of supply of medicines at all times. It will have short-term measures to present, prevent and respond to critical shortages, with the solidarity Member States, for which the Member States have been calling for a long while. </p>
<p class="contents">We’re going to have an earlier adoption of the list of critical medicines. Many of you have asked, What are we doing with that? I just wanted to say that this will be prepared and we will be putting this forward by the end of this year. It will also be looking at guidance on procurement of medicines, but it will also be looking at what we’re going to be doing in the long term with additional measures that we need to do to have structural change, building the right environment for investment and the right structures through, for example, EU FAB, so that we have solidarity. </p>
<p class="contents">We will be looking at the possibility of stockpiling in our communication and also a revision of the joint procurement. So I’m looking forward to this communication coming forward and being able to present it to you and discussing it with you.</p>
<p class="contents">In terms of the re-shore of production of all critical medicines to the EU, I want to just say two words. Open strategic autonomy is a major political objective of the Commission, and I think it is also a major lesson learned from the COVID crisis, and we want to de-risk, but we do not want to decouple from the global economy. The vulnerabilities analysis of the Union list of critical medicines will be informing us, because you need to see this as a toolbox on which medicines we need to diversify in terms of supply or reshoring. There is no one size-fits-all-approach, so we really need to base ourselves on medicines. We are going to have, and this is already in the reform that I hope that you will be debating as quickly as possible, we have proposed a new European alert system. We need to have earlier notification of shortages and of withdrawals so that we can have prevention plans of shortages and stronger EU coordination and mechanisms. </p>
<p class="contents">In terms of APIs, many of you have said this and I will not repeat myself, but in order to ensure this, we need to have a healthy environment for the pharmaceutical and the biopharmaceutical industries in the EU. We need to look at manufacturing flexibility and skilled labour, and this can help us build up the situation that we are working towards to have more secure supply chains and local EU production in order to enable a healthy environment. </p>
<p class="contents">On funding, a lot of financial instruments can already support strong medicines production, for instance, from the Recovery and Resilience Facility at the EU level and the recently proposed STEP mechanism supports innovative biotechnology, and also national funds can be made available.</p>
<p class="contents">Because there was a very clear question on the issue of the Critical Medicines Act – and I don’t want to not answer that, I’m sorry I have gone over time, but so much has been said – we are open to explore a new approach for the Critical Medicines Act. I’ve said this before, but this legislative initiative requires very thorough preparation. We need to assess the industrial, the trade and the commercial dimensions and the immediate legislative priority for us – and I think for all of us now – is this pharmaceutical reform, which proposes a toolbox to address shortages and boost our security of supply in a structured way. </p>
<p class="contents">This is what we need in a European Health Union. We have achieved over the past 20 years – and the last time there was a reform I think was 19 years ago – is to have safe and effective medicines in the EU. But what we have not achieved is to have a single market for medicines and that’s what we are putting forward in our pharmaceutical reform. </p>
<p class="contents">I’m counting on your support for a swift discussion and adoption of this legislation, because ultimately it is the best way forward to mitigate shortages and to ensure that all medicines reach all patients whenever they need them. That’s what we’re all committed to do here.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-269-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28615.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20231003-15:19:21&amp;playerEndTime=20231003-15:19:30" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">President. – </span></span>  The debate is closed.</p>
<p class="contents"><span class="bold"><span class="italic">Written statements (Rule 171)</span></span></p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-269-2500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197394.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Josianne Cutajar (S&amp;D), </span></span>  <span class="italic">in writing</span><span class="bold">.</span> – Between 2017 and 2019 there has been a 60% increase in shortage notifications for essential medicines and active pharmaceutical ingredients in our Union, with the situation only having gotten worse in 2022.</p>
<p class="contents">What is clear for all to see is that medicines shortages are a real threat to the wellbeing of our citizens, with a disproportionate impact on the most vulnerable among us.</p>
<p class="contents">For this reason, the status quo is simply intolerable.</p>
<p class="contents">We need to foster effective strategic healthcare autonomy. For this reason we must not only focus on mitigating drug shortages, but also on implementing a preventive strategy and increasing production and innovation with the EU.</p>
<p class="contents">I urge the Commission to work towards a coherent and robust support policy, which aims to bolster our resilience in the face of possible health crises, boost the European pharmaceutical industrial ecosystem, make healthcare systems sustainable and increase access to treatments for patients.</p>
<p class="contents">One does not choose to get sick, but it is indeed our common political choice and responsibility to address medicines shortages, and ultimately ensure accessible and affordable cures for all Europeans.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-269-5000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/112747.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Romana Jerković (S&amp;D), </span></span>  <span class="italic">napisan</span><span class="bold">.</span> – Lijekovi za ublažavanje simptoma prehlade i gripe, sirupi protiv kašlja, lijekovi za regulaciju visokog krvnog tlaka su samo neki u nizu od lijekova koji nedostaju. Uzroci nestašice su različiti, a ishod je isti-naši sugrađani nemaju pristup prijeko potrebnim lijekovima i antibioticima. Zajednički proeuropski odgovor je ključni faktor kojim možemo poduzeti adekvatne mjere. Europska zdravstvena unija predstavlja temelj naše budućnosti. Proračunom od 5,3 milijarde eura EU jasno prioritizira zdravlje. Ako nas je pandemija covida-19 naučila ičemu, onda je to sigurno međusobna suradnja. Pokretanjem proizvodnih pogona istovremeno bismo djelovali na dvije razine. S jedne strane smanjili bismo ili onemogućili nestašicu lijekova, a druge strane otvorili bismo brojna nova radna mjesta. Shodno tomu, reducirali bismo uvoz lijekova iz Kine. Zajednička nabava cjepiva protiv koronavirusa uvelike je doprinijela njegovom suzbijanju. Jučer je to bila korona, a sutra tko zna što. Ne možemo i ne smijemo si dopustiti ponavljanje istog scenarija. Moramo prioritizirati jačanje zdravstvenih sustava na razini EU-a. Dužni smo omogućiti našim pacijentima pristup lijekovima koji su im potrebni po pristupačnim cijenama. Trebamo utvrditi koji lijekovi nedostaju. Moramo imati europsku farmaceutsku strategiju kako bi Europa bila autonomna. Pristup lijekovima ne može se ograničavati u slučajevima nestašice, rata ili inflacije.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-269-7500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197721.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">César Luena (S&amp;D), </span></span>  <span class="italic">por escrito</span><span class="bold">.</span> – La Delegación Socialista Española impulsó un debate exigiendo a la Comisión una legislación de apoyo dirigida a desarrollar una autonomía estratégica europea en materia de principios activos farmacéuticos (APIs) y medicamentos.</p>
<p class="contents">La escasez de medicamentos es un problema crónico y sistémico en Europa, que se ha agravado en los últimos años. Este año, sin ir más lejos, todos los Estados miembros reportaron desabastecimientos, especialmente de analgésicos y formas farmacéuticas pediátricas, que pusieron en riesgo a los pacientes europeos. Asimismo, La UE ha perdido competitividad en investigación e innovación en las últimas décadas, pasando de ser un líder global a quedarse a la zaga frente a países como China o Estados Unidos.</p>
<p class="contents">Necesitamos medidas legislativas, más allá de lo considerado en la revisión de la legislación farmacéutica general, en línea con lo publicado para las otras 5 áreas de dependencia definidas por la comisión (materias primas, baterías, hidrógeno limpio, semiconductores y tecnologías Hedge and Cloud). Nuestro objetivo debe ser aumentar la cuota de mercado europeo en la producción de medicamentos esenciales, APIs y medicamentos innovadores, para fortalecer la resiliencia y la sostenibilidad de los sistemas sanitarios, impulsar la industria europea y mejorar el acceso a los tratamientos para los pacientes.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-270-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/212855.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Alin Mituța (Renew), </span></span>  <span class="italic">in writing</span><span class="bold">.</span> – European citizens want more competences at the EU level to deal with health problems and future crises, as they expressed during the Conference on the Future of Europe. Despite the fact that we have a single market, there remains significant disparities among member states when it comes to access to healthcare services and medicine. Introducing minimum quality standards for healthcare could be the first step in ensuring equal access to adequate medical treatment for all European citizens, regardless of where they live, work, or travel in Europe and need medical help. This could entail the introduction of a unified set of criteria established by EU legislation. An important step in ensuring access to life-saving medicines for all European citizens should be the adoption of an EU list of essential medicines. Furthermore, we should address medicine shortages by establishing strategic stocks, but also by encouraging member states to collectively negotiate prices when purchasing equipment and medicine. Moreover, the European Union's industrial strategy should give special attention to building strategic autonomy and resilience in this sector.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-270-5000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/40599.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sirpa Pietikäinen (PPE), </span></span>  <span class="italic">kirjallinen</span><span class="bold">.</span> – Arvoisa puhemies, Olemme Euroopassa isojen kysymysten äärellä. Mikä on paikkamme maailmassa, kenestä olemme riippuvaisia? Kenen hyväntahtoisuudesta ja yhteistyöstä riippuu yritystemme, teollisuutemme ja yhteiskuntiemme toiminta, jopa kansalaistemme terveys? Venäjän hyökkäyssota Ukrainassa, globaali kahtiajako ja geopoliittiset jännitteet ovat syystäkin avanneet silmämme strategisen autonomian vahvistamisen tarpeelle. Yhteistyö ja keskinäisriippuvuudet voivat olla paitsi mahdollisuus myös uhka. Keskinäisriippuvuudet alkavat näkyä nyt negatiivisesti myös terveyden saralla ja lääkkeissä. On haitallista, että EU on lääkkeiden valmistuksessa ja toimituksessa vakavasti riippuvainen kahdesta jättiläisestä: Kiinasta ja Intiasta. Jos lääketehtaiden toiminta näissä maissa vaarantuu tai toimitusvirrat tyrehtyvät, lääkkeistä riippuvaisten eurooppalaisten terveys on vaarassa. Monen kohdalla kyseessä voi todella olla elämän ja kuoleman kysymys. Nyt, kun EU:n lääkelainsäädäntöä uudistetaan, on oikea hetki varmistaa, että teemme lainsäädäntöä, joka rohkaisee lääkealan innovaatioita ja tutkimusta Euroopassa sekä tuo myös tuotantoa EU:n ulkopuolelta takaisin Eurooppaan. EU:n täytyy olla nykyistä isompi tekijä lääkepulan taltuttamisessa ja parantaa myös terveydenhuollon strategista autonomiaa ja turvallisuutta. On aika siirtää katseemme lääkeomavaraisuuteen sekä innovaatioissa, tutkimuksessa että tuotannossa. Meidän täytyy vahvistaa Euroopan lääkeomavaraisuutta, jotta turvaamme potilaidemme hyvän hoidon jatkossakin. Kiitos.</p></td><td width="16"> </td></tr></table></td></tr></table><table width="100%" border="0" cellspacing="0" cellpadding="5"><tr class="footerdocwin"><td>Last updated: 20 October 2023</td><td align="right"><a target="_blank" href="/legal-notice/en">Legal notice</a> - <a target="_blank" href="/privacy-policy/en">Privacy policy</a></td></tr></table></td></tr></table></body></html>
